Novo Nordisk and Eli Lilly began pushing back
Effector T cells rely on extracellular serine as a key immune-metabolite for de novo nucleotide biosynthesis and cellular expansion 69
Samina Afreen, M.D., an endocrinologist who specializes in diabetes and obesity at UVA Health in Charlottesville, Virginia
Among patients with obesity undergoing bariatric surgery, the proportion taking a GLP-1 receptor agonist in the year before their procedure rose sharply between 2018 and 2023, researchers reported
And part of that messaging was because we didn't have solutions other than bariatric surgery to allow people to become healthier, perhaps at a lower body weight
Deroux A, Dumestre-Perard C, Dunand-Faure C, Bouillet L, Hoffmann P